CX3CR1 Deficiency Alters Microglial Activation and Reduces Beta-Amyloid Deposition in Two Alzheimer's Disease Mouse Models

Cited by (510)

Items 301–400 of 510

1. Computational identification of potential multi-drug combinations for reduction of microglial inflammation in Alzheimer disease
   Thomas J. Anastasio · 2015 · Frontiers in Pharmacology
2. Prospective Study of Common Variants inCX3CR1and Risk of Macular Degeneration
   Debra Ann Schaumberg, Lynda M. Rose, Margaret M. DeAngelis, Richard D. Semba, Gregory S. Hageman, Daniel I. Chasman · 2013 · JAMA Ophthalmology
3. RETRACTED: Role of fractalkine/CX3CR1 signaling pathway in the recovery of neurological function after early ischemic stroke in a rat model
   Yanzhi Liu, Chun Wang, Qian Wang, Yongzhong Lin, Yusong Ge, Dongmei Li, Gengsheng Mao · 2017 · Life Sciences · Retracted
4. Microvessel occlusions alter amyloid-beta plaque morphology in a mouse model of Alzheimer’s disease
   Yuying Zhang, Evan D. Bander, Yurim Lee, Celia A. Muoser, Chris B. Schaffer, Nozomi Nishimura · 2019 · Journal of Cerebral Blood Flow & Metabolism
5. Dynamic Neuroimmune Profile during Mid-life Aging in the Female Brain and Implications for Alzheimer Risk
   Aarti Mishra, Yuan Shang, Yiwei Wang, Eliza R. Bacon, Fei Yin, Roberta Dı́az Brinton · 2020 · iScience
6. The temporal dynamics of plasma fractalkine levels in ischemic stroke: association with clinical severity and outcome
   Gerrit Maximilian Große, Anita B. Tryc, Meike Dirks, Ramona Schuppner, Henning Pflugrad, Ralf Lichtinghagen, Karin Weißenborn, Hans Worthmann · 2014 · Journal of Neuroinflammation
7. Microglia Susceptibility to Free Bilirubin Is Age-Dependent
   Ana Rita Vaz, Ana S. Falcão, Eleonora Scarpa, Carlotta Semproni, Dora Maria Tuna Oliveira Brites · 2020 · Frontiers in Pharmacology
8. Functional analysis of CX3CR1 in human induced pluripotent stem (iPS) cell‐derived microglia‐like cells
   Murai, Nobuhito, Mitalipova, Maisam, Jaenisch, Rudolf · 2020 · European Journal of Neuroscience
9. Chronic administration of prebiotics and probiotics ameliorates pathophysiological hallmarks of Alzheimer’s disease in a APP/PS1 transgenic mouse model
   Daniele Lana, Chiara Traini, Irene Bulli, Giorgia Sarti, Giada Magni, Selene Attorre, Maria Grazia Giovannini, Maria Giuliana Vannucchi · 2024 · Frontiers in Pharmacology
10. Longitudinal chemokine profile expression in a blood-brain barrier model from Alzheimer transgenic versus wild-type mice
    Julie Vérité, Thierry Janet, Damien Chassaing, Bernard Fauconneau, Hanitriniaina Rabeony, Guylène Page · 2018 · Journal of Neuroinflammation
11. Genetically enhancing the expression of chemokine domain of CX3CL1 fails to prevent tau pathology in mouse models of tauopathy
    Bemiller, Shane M., Maphis, Nicole M., Formica, Shane V., Wilson, Gina N., Miller, Crystal M., Xu, Guixiang, Kokiko-Cochran, Olga N., Kim, Ki-Wook, Jung, Steffen, Cannon, Judy L. et al. · 2018 · Journal of Neuroinflammation
12. Elevated levels of soluble fractalkine and increased expression of CX3CR1 in neuropsychiatric systemic lupus erythematosus
    Ling Chuan Guo, Xiaoye Lu, Yuan Wang, Chunde Bao, Shun‐le Chen · 2017 · Experimental and Therapeutic Medicine
13. Baicalein ameliorates Alzheimer's disease via orchestration of CX3CR1/NF-κB pathway in a triple transgenic mouse model
    Xinmei Xie, Jiao-Jiao Hao, Jun-Zhuo Shi, Yunfeng Zhou, Pengfei Liu, Feng Wang, Xiao-Ming Zheng, Xiuying Yu, Chenchen Wang, Yi Yan et al. · 2023 · International Immunopharmacology
14. Targeting the hematopoietic system for the treatment of Alzheimer’s disease
    Antoine Lampron, David Gosselin, Serge Rivest · 2010 · Brain Behavior and Immunity
15. N-3 polyunsaturated fatty acid and neuroinflammation in aging and Alzheimer's disease
    Sophie Layé, Charlotte Madore, Isabelle St‐Amour, Jean-Christophe Delpech, Corinne Joffre, Agnès Nadjar, Frédéric Calon · 2015 · Nutrition and Aging
16. Modulation of inflammatory responses by fractalkine signaling in microglia
    Inoue, Koichi, Morimoto, Hiroyuki, Ohgidani, Masahiro, Ueki, Takatoshi · 2021 · PLOS ONE
17. The effect of Abi3 locus deletion on the progression of Alzheimer’s disease-related pathologies
    Karahan, Hande, Smith, Daniel C., Kim, Byungwook, McCord, Brianne, Mantor, Jordan, John, Sutha K., Al-Amin, Md Mamun, Dabin, Luke C., Kim, Jungsu · 2023 · Frontiers in Immunology
18. The Role of Microglia in the (Mal)adaptive Response to Traumatic Experience in an Animal Model of PTSD
    Kesem Nahum, Doron Todder, Joseph Zohar, Hagit Cohen · 2022 · International Journal of Molecular Sciences
19. Microglial VPS35 deficiency regulates microglial polarization and decreases ischemic stroke-induced damage in the cortex
    Shi-Yang Ye, Joanna E. Apple, Xiao Ren, Fu‐Lei Tang, Ling-Ling Yao, Yong-Gang Wang, Lin Mei, Yuan-Guo Zhou, Wen‐Cheng Xiong · 2019 · Journal of Neuroinflammation
20. Brain Damage - Bridging Between Basic Research and Clinics
    Alina González-Quevedo · 2012 · InTech eBooks
21. Haploinsufficiency of microglial MyD88 ameliorates Alzheimer's pathology and vascular disorders in APP / PS1 ‐transgenic mice
    Wenqiang Quan, Qinghua Luo, Wenlin Hao, Inge Tomic, Tomomi Furihata, Walter Schulz‐Schaeffer, Michael Dieter Menger, Klaus C Fassbender, Yang Liu · 2021 · Glia
22. An overview of the possible therapeutic role of SUMOylation in the treatment of Alzheimer’s disease
    Serena Marcelli, Elena Ficulle, Laura Piccolo, Massimo Corbo, Marco Feligioni · 2017 · Pharmacological Research
23. The effect of dipeptidyl peptidase IV on disease-associated microglia phenotypic transformation in epilepsy
    Zhicheng Zheng, Peiyu Liang, Baohua Hou, Xin Lu, Qianwen Ma, Xiao-Min Yu, Song Hee Han, Biwen Peng, Tao-Xiang Chen, Wanhong Liu et al. · 2021 · Journal of Neuroinflammation
24. An overlooked subset of Cx3cr1wt/wt microglia in the Cx3cr1CreER-Eyfp/wt mouse has a repopulation advantage over Cx3cr1CreER-Eyfp/wt microglia following microglial depletion
    Kai Zhou, Jinming Han, Harald Lund, Nageswara Rao Boggavarapu, Volker Martin Lauschke, Shinobu Goto, Huaitao Cheng, Yuyu Wang, Asuka Tachi, Cuicui Xie et al. · 2022 · Journal of Neuroinflammation
25. Adipose tissue as a therapeutic target for vascular damage in Alzheimer's disease
    Miriam Bettinetti‐Luque, Laura Trujillo‐Estrada, Eduardo García‐Fuentes, Juana Andreo‐Lopez, Raquel Maria Sanchez-Varo, Lourdes Garrido‐Sánchez, Angela Gomez Mediavilla, Manuela G. López, Melissa García‐Caballero, Antonia Gutiérrez et al. · 2023 · British Journal of Pharmacology
26. Neuron–microglia interactions in neuroinflammation
    Tetsuya Mizuno · 2015 · Clinical and Experimental Neuroimmunology
27. Microglia of the Brain: Origin, Structure, Functions
    Olga Sergeevna Alekseeva, Olga V. Kirik, E. G. Gilerovich, Dmitriy E. Korzhevsky · 2019 · Journal of Evolutionary Biochemistry and Physiology
28. Blood brain barrier as an interface for alcohol induced neurotoxicity during development
    Michele Siqueira, Joice Stipursky · 2022 · NeuroToxicology
29. Chronic acrylamide exposure resulted in dopaminergic neuron loss, neuroinflammation and motor impairment in rats
    Ying Liu, Yiqi Wang, Xing Zhang, Yang Jiao, Lian Duan, Lingling Dai, Hong Yan · 2022 · Toxicology and Applied Pharmacology
30. Knockout of fractalkine receptor Cx3cr1 does not alter disease or microglial activation in prion-infected mice
    James F. Striebel, Brent Race, James A. Carroll, Katie L. Phillips, Bruce W. Chesebro · 2016 · Journal of General Virology
31. Deletion of Abi3/Gngt2 influences age-progressive amyloid β and tau pathologies in distinctive ways
    Ibanez, Kristen R., McFarland, Karen N., Phillips, Jennifer, Allen, Mariet, Lessard, Christian B., Zobel, Lillian, De La Cruz, Elsa Gonzalez, Shah, Shivani, Vo, Quan, Wang, Xue et al. · 2022 · Alzheimer's Research & Therapy
32. Concentration and proteolysis of CX3CL1 may regulate the microglial response to CX3CL1
    Dylan J. Finneran, Qingyou Li, Meena S. Subbarayan, Aurélie Joly‐Amado, Siddharth G. Kamath, Daniela G. Dengler, Marcia N. Gordon, Michael R. Jackson, David Morgan, Paula C. Bickford et al. · 2022 · Glia
33. Phenomic Microglia Diversity as a Druggable Target in the Hippocampus in Neurodegenerative Diseases
    Daniele Lana, Giada Magni, Elisa Landucci, Gary L. Wenk, Domenico Edoardo Pellegrini-Giampietro, Maria Grazia Giovannini · 2023 · International Journal of Molecular Sciences
34. CX3CL1 Regulation of Gliosis in Neuroinflammatory and Neuroprotective Processes
    Irene L. Gutiérrez, David Martín‐Hernández, Karina S. MacDowell, Borja García‐Bueno, Javier R. Caso, Juan Carlos Leza, José L. M. Madrigal · 2025 · International Journal of Molecular Sciences
35. Proinflammatory cytokines and their receptors as druggable targets to alleviate pathological pain
    Theodora Kalpachidou, Lydia Riehl, Clemens L. Schöpf, Buket Uçar, Michaela Kress · 2022 · Pain
36. Age-dependent changes on fractalkine forms and their contribution to neurodegenerative diseases
    Jaime L. Eugenín, Laura Eugenín-von Bernhardi, Rommy von Bernhardi M. · 2023 · Frontiers in Molecular Neuroscience
37. MyD88 Is Dispensable for Cerebral Amyloidosis and Neuroinflammation in APP/PS1 Transgenic Mice
    Tara M. Weitz, David Gate, Kavon P. Rezai-Zadeh, Terrence Town · 2014 · American Journal Of Pathology
38. Analysis of CX3CR1 haplodeficiency in male and female APPswe/PSEN1dE9 mice along Alzheimer disease progression
    Anne-Laure Hemonnot-Girard, Audrey Valverde, Jennifer Hua, Charlene Delaygue, Nathalie Linck, Tangui Maurice, François Rassendren, Hélène Hirbec · 2020 · Brain Behavior and Immunity
39. Pathogenesis and therapeutic applications of microglia receptors in Alzheimer’s disease
    Jiao Fu, RuoXuan Wang, JiHui He, Xiaojing Liu, Xinxin Wang, JuMing Yao, Ye Liu, Chongzhao Ran, Qingsong Ye, Yan He · 2025 · Frontiers in Immunology
40. Age Moderates the Effects of Traumatic Brain Injury on Beta-Amyloid Plaque Load in APP/PS1 Mice
    Jessica Marie Collins, Anna Elizabeth King, Adele Woodhouse, Matthew Kirkcaldie, James Clement Vickers · 2019 · Journal of Neurotrauma
41. Recent Developments in Targeting Neuroinflammation in Disease
    Allen T. Hopper, Brian M. Campbell, Henry W. Kao, Sean A. Pintchovski, Roland G. W. Staal · 2012 · Annual reports in medicinal chemistry
42. Surgical Trauma Exacerbates Cognitive Deficits and Neuroinflammation in Aged Rats: The Role of CX3CL1-CX3CR1 Signaling
    Zhe Li, Xuezhao Cao, Hong Ma, Yong Cui, Xiaoqian Li, Na Wang, Yongjian Zhou · 2018 · Journal of Neuropathology & Experimental Neurology
43. Protective role of CX3CR1 signalling in resident cells of the central nervous system during experimental herpes simplex virus encephalitis.
    Rafik Menasria, C. Canivet, J. Piret, J. Gosselin, G. Boivin · 2017 · Journal of General Virology
44. Internalization of extracellular Tau oligomers in Alzheimer’s disease
    Subashchandrabose Chinnathambi, Nagaraj Rangappa, Madhura Chandrashekar · 2025 · Advances in clinical chemistry
45. Glycogen synthase kinase-3β regulates fractalkine production by altering its trafficking from Golgi to plasma membrane: implications for Alzheimer’s disease
    Almudena Fuster-Matanzo, Jerónimo Jurado‐Arjona, Stefano Benvegnù, Esther García, Patricia Martín-Maestro, Raquel Gómez‐Sintes, Félix Hernández, Jesús Ávila · 2016 · Cellular and Molecular Life Sciences
46. Integrative analysis of DNA methylation and gene expression identifies genes associated with biological aging in Alzheimer's disease
    Bo‐Hyun Kim, A. Vasanthakumar, Qing-Qin S. Li, K. Nudelman, S. Risacher, J. Davis, K. Idler, Jongmin Lee, S. Seo, J. Waring et al. · 2022 · Alzheimer's & Dementia
47. Molecular aspects of the pathogenesis and current approaches to pharmacological correction of Alzheimer’s disease
    Michail S. Kukharsky, Р. К. Овчинников, Сергей Олегович Бачурин · 2015 · S S Korsakov Journal of Neurology and Psychiatry
48. Modulation of microglia activation and Alzheimer's disease
    Pavithra Suresh, Sarayut Phasuk, Ingrid Y. Liu · 2021 · Tzu Chi Medical Journal
49. Therapeutic Targets in Innate Immunity to Tackle Alzheimer’s Disease
    Maria L. Serradas, Yingying Ding, Paula Martorell, Ida Kulińska, Sergio Castro‐Gomez · 2024 · Cells
50. Differences in Immune-Related Genes Underlie Temporal and Regional Pathological Progression in 3xTg-AD Mice
    A. Fernandes, C. Caldeira, C. Cunha, E. Ferreiro, A. R. Vaz, D. Brites · 2022 · Cells
51. Alteration in peritoneal cells with the chemokine CX3CL1 reverses age-associated impairment of recognition memory
    Yoshinori Takei, Yoko Amagase, Keiko Iida, Tomohiro Sagawa, Ai Goto, Ryuichi Kambayashi, Hiroko Izumi‐Nakaseko, Akio Matsumoto, Shinichi Kawai, Atsushi Sugiyama et al. · 2022 · GeroScience
52. Polymorphisms in the microglial marker molecule CX3CR1 affect the blood volume of the human brain
    Mai Sakai, Hikaru Takeuchi, Zhiqian Yu, Yoshie Kikuchi, Chiaki Ono, Yuta Takahashi, Fumiaki Ito, Hiroo Matsuoka, Osamu Tanabe, Jun Yasuda et al. · 2018 · Psychiatry and Clinical Neurosciences
53. The intricate interplay between microglia and adult neurogenesis in Alzheimer’s disease
    Iris Früholz, Melanie Meyer‐Luehmann · 2024 · Frontiers in Cellular Neuroscience
54. Effect of acute lipopolysaccharide-induced inflammation in intracerebroventricular-streptozotocin injected rats
    Andrew S. Murtishaw, Chelcie F. Heaney, Monica M. Bolton, Jonathan J. Sabbagh, Michael A. Langhardt, Jefferson W. Kinney · 2015 · Neuropharmacology
55. Fractalkine and Other Chemokines in Primary Biliary Cirrhosis
    Shinji Shimoda, Carlo Francesco Selmi, Merrill Eric Gershwin · 2011 · International Journal of Hepatology
56. Phagocytosis of aggrecan-positive perineuronal nets surrounding motor neurons by reactive microglia expressing MMP-9 in TDP-43Q331K ALS model mice
    Sang Won Cheung, Emily F. Willis, David G. Simmons, Mark C. Bellingham, Peter G. Noakes · 2024 · Neurobiology of Disease
57. Fractalkine/CX3CR1 axis is critical for neuroprotection induced by hypoxic postconditioning against cerebral ischemic injury
    Lixuan Zhan, Meiqian Qiu, Jianhua Zheng, Meijing Lai, Kunqin Lin, Jiahua Dai, Weiwen Sun, En Xu · 2024 · Cell Communication and Signaling
58. Increment of CSF fractalkine-positive microvesicles preceded the spatial memory impairment in amyloid beta neurotoxicity
    Leila Karimi‐Zandi, Maryam Zahmatkesh, Gholamreza Hassanzadeh, Soheila Hosseinzadeh · 2022 · Cytokine
59. Temporal-logic analysis of microglial phenotypic conversion with exposure to amyloid-β
    Thomas J. Anastasio · 2014 · Molecular BioSystems
60. Potential significance of CX3CR1 dynamics in stress resilience against neuronal disorders
    Kōichi Inoue · 2022 · Neural Regeneration Research
61. Headmasters: Microglial regulation of learning and memory in health and disease
    Laetitia Weinhard, Paolo d’Errico, Tuan Leng Tay · 2018 · AIMS molecular science
62. Short-Term Effects of Microglia-Specific Mitochondrial Dysfunction on Amyloidosis in Transgenic Models of Alzheimer’s Disease
    Johannes Steffen, Jan Stenzel, Saleh Mohamed Ibrahim, Jens Pahnke · 2018 · Journal of Alzheimer s Disease
63. Four-dimensional microglia response to anti-Aβ treatment in APP/PS1xCX3CR1/GFP mice
    Mónica Garcı́a-Alloza, Laura A. Borrelli, Diana H. Thyssen, Suzanne E. Hickman, Joseph B. El Khoury, Brian J. Bacskai · 2013 · IntraVital
64. Cell ageing: a flourishing field for neurodegenerative diseases
    Dora Maria Tuna Oliveira Brites · 2015 · AIMS molecular science
65. The Implication of Glial Metabotropic Glutamate Receptors in Alzheimer’s Disease
    Izabella B.Q. de Lima, Fabíola M. Ribeiro · 2021 · Current Neuropharmacology
66. Blood–brain barrier and neurological diseases
    Yukio Takeshita, Richard M. Ransohoff · 2015 · Clinical and Experimental Neuroimmunology
67. Animal Models of Alzheimer’s Disease: Utilization of Transgenic Alzheimer’s Disease Models in Studies of Amyloid Beta Clearance
    Tarja Malm, Johanna M. Magga, Jari Koıstınaho · 2012 · Current Translational Geriatrics and Experimental Gerontology Reports
68. Thermal Injury Lowers the Threshold for Radiation-Induced Neuroinflammation and Cognitive Dysfunction
    Jonathan D. Cherry, Jacqueline P. Williams, M. Kerry O’Banion, John A. Olschowka · 2013 · Radiation Research
69. Differential expression of long non-coding RNAs in the hippocampus of mice exposed to PM2.5 in Dalian, China
    Jie Li, Longying Zhang, Jiaqi Wang, Ruxue Jia, Xiao Zhang, Xiaojing Li, Ying Fu, Laiyu Song · 2021 · Environmental Science and Pollution Research
70. The role of efferocytosis in ischemic stroke and insights from retinopathy
    Carol Morris, Mohamed A. Sadek, Pooja Modi, Seif E. Abdelnaem, Nancy J. Rusch, Esraa Shosha, Abdelrahman Y. Fouda · 2025 · Trends in Neurosciences
71. Microglial interferon signaling and Aβ plaque pathology are enhanced in female 5xFAD Alzheimer’s disease mice, independent of estrous cycle stage
    L. Calcines-Rodríguez, Nikita Noyes-Martel, Jennifer D. Becker, S. K. Nguyen, Mark Osabutey, Lee Trojanczyk, Ania Katarzyna Majewska, M. Kerry O’Banion · 2025 · Journal of Neuroinflammation
72. Microglia-glioblastoma crosstalk mediates glioblastoma invasion at the far infiltration zone
    Felix Christopher Nebeling, Falko Fuhrmann, Manuel Mittag, Fabrizio Musacchio, Henrike Antony, Nala Gockel, Lea Lydia Friker, Sonia Leonardelli, Severin Filser, A. Deli et al. · 2026 · Immunity
73. Advances in Drug Discovery and Development in Geriatric Psychiatry
    Alexander C. Conley, PAUL A. NEWHOUSE · 2018 · Current Psychiatry Reports
74. Unraveling the complexity of microglial responses in traumatic brain and spinal cord injury
    Rebecca J. Henry, David J. Loane · 2025 · Handbook of clinical neurology
75. Inducible deletion of DGAT1 and 2 from microglia exacerbates neurodegeneration and endolysosomal lipid accumulation in male PS19 mice
    G. Travis Tabor, Alexandra Litvinchuk, Yun Chen, Austin Allison, Elizabeth Wen Sun, Bettina van Lengerich, Sonnet S. Davis, Elizabeth West, Johannes C. M. Schlachetzki, Carisa Zeng et al. · 2026 · Cell Reports
76. Synaptotagmin‐11 regulates immune functions of microglia in vivo
    Feifan Zhang, Dong Yang, Jingchen Li, Cuilian Du, Xinran Sun, Wanru Li, Fengwei Liu, Yiwei Yang, Yuhong Li, Lei Fu et al. · 2023 · Journal of Neurochemistry
77. Determinants of regeneration in the injured nervous system
    Michael A. Selzer, Stéphanie Clarke, Leonardo G. Cohen, Gert Kwakkel, Robert H. Miller · 2014 · Cambridge University Press eBooks
78. Inhibition of microfold cells ameliorates early pathological phenotypes by modulating microglial functions in Alzheimer’s disease mouse model
    Namkwon Kim, In Gyoung Ju, Seung Ho Jeon, Yeongae Lee, Minji Jung, Min Sung Gee, Jae Seok Cho, Kyung‐Soo Inn, Lee Ann Garrett‐Sinha, Myung Sook Oh et al. · 2023 · Journal of Neuroinflammation
79. SCRN: Single-Cell Gene Regulatory Network Identification in Alzheimer's Disease
    Wentao Zhu, Zhi‐Qiang Du, Ziang Xu, Defu Yang, Minghan Chen, Qianqian Song · 2024 · IEEE Transactions on Computational Biology and Bioinformatics
80. CX3CR1: a potential microglia-specific PET imaging target in Alzheimer’s and Parkinson’s diseases
    Hongzhi Yang, Yongle Wang, Yulong Xu, Changning Wang · 2025 · Frontiers in Pharmacology
81. The complex role of the chemokine CX3CL1/Fractalkine in major depressive disorder: A narrative review of preclinical and clinical studies
    Samuel Bridge, Sophia N. Karagiannis, Alessandra Borsini · 2024 · Brain Behavior & Immunity - Health
82. Implications of fractalkine on glial function, ablation and glial proteins/receptors/markers—understanding its therapeutic usefulness in neurological settings: a narrative review
    Deepraj Paul, Duraiswamy Basavan · 2022 · Future Journal of Pharmaceutical Sciences
83. Adenosine Receptors and Alzheimer’s Disease
    David L Blum, Ursula S. Sandau, Cyril Laurent, Vânia L. Batalha, Antoine Leboucher, Malika Hamdane, Florence Pasquier, Detlev Boison, Luc Buée, Luísa Vaqueiro Lopes · 2012 · Springer eBooks
84. The Amyloid-beta rich CNS environment alters myeloid cell functionality independent of their origin
    Natalia Drost, Judith Houtman, Zoltán Cseresnyés, Raluca Aura Niesner, Jan-Leo Rinnenthal, Kelly R. Miller, Stefan Prokop, Frank L. Heppner · 2020 · Scientific Reports
85. Molecular Mechanisms of Acute Brain Injury and Ensuing Neurodegeneration
    J. Francisco, Jose M., Nicole Mahy, Manuel J. · 2012 · InTech eBooks
86. Single-cell RNA-seq reveals that glioblastoma recapitulates normal brain development
    Charles Couturier, Shamini Ayyadhury, Phuong Uyen Le, Jean Monlong, Gabriele Riva, Redouane Allache, Salma Baig, Xiaohua Yan, Mathieu Bourgey, Changseok Lee et al. · 2018 · bioRxiv (Cold Spring Harbor Laboratory)
87. Integrative Spatial Omics for Systems-Level Mapping of Pathological Niches
    Angela R.S. Kruse, Roy Lardenoije, Lukasz G. Migas, Claire F. Scott, Cody R. Marshall, Morad C. Malek, Adel Eskaros, Thai H. Pham, Kristie I. Aamodt, Madeline E. Colley et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
88. Morroniside Modulates Microglia Polarization via the CX3CL1/CX3CR1/PU.1 Axis in ApoE4 Transgenic Mice
    Ying‐Yan Chang, Xu‐Hui Zheng, Meng‐Wei Wang, Qianwen Zhang, Ya‐Tong Gao, Yue‐Nan Wang, Yi Sun, Hao‐Hui Fan, Xi Li, Li-Da Du et al. · 2026 · Phytotherapy Research
89. Microglial Drivers of Alzheimer's Disease Pathology: An Evolution of Diverse Participating States
    Madison K. Kuhn, Elizabeth A. Proctor · 2024 · Proteins Structure Function and Bioinformatics
90. Tilting homeostatic and dyshomeostatic microglial balance in health and disease: transforming growth factor-beta1 as a critical protagonist
    Nicolas Hugues, Yu Luo · 2024 · Neural Regeneration Research
91. Neuroinflammation in Dementia—Therapeutic Directions in a COVID-19 Pandemic Setting
    Mateusz Łuc, Marta Woźniak, Joanna Rymaszewska · 2022 · Cells
92. Trophic factors intervention regenerates the nestin-expressing cell population in a model of perinatal excitotoxicity: Implications for perinatal brain injury and prematurity
    Araceli Espinosa de los Monteros · 2016 · Integrative Molecular Medicine
93. Crosstalk between NLRP3 inflammasome and calpain in Alzheimer's disease
    Rumaiza Mamsa, Kedar Sudhir Prabhavalkar, Lokesh Kumar Bhatt · 2023 · European Journal of Neuroscience
94. Pneumococcal Meningitis Induces Hearing Loss and Cochlear Ossification Modulated by Chemokine Receptors CX3CR1 and CCR2
    Keiko Hirose, Song Zhe Li, Ruth M. Gill, Jared J. Hartsock · 2024 · Journal of the Association for Research in Otolaryngology
95. Time-lapse Whole-field Fluorescence Imaging of Microglia Processes Motility in Acute Mouse Hippocampal Slices and Analysis
    Bernadette Basilico, Barbara Cortese, Patrizia Ratano, Silvia Di Angelantonio, Davide Ragozzino · 2019 · BIO-PROTOCOL
96. Levels of preoperative cerebrospinal fluid pro‐inflammatory mediators and chronic pain after total knee arthroplasty surgery
    Jungo Kato, Reiko Murase, Rie Minoshima, Fanglin Lu, Tomoko Toramaru, Yasuo Niki, Shizuko Kosugi, Hiroshi Morisaki · 2023 · Acta Anaesthesiologica Scandinavica
97. Neonatal Proinflammatory Stress and Expression of Neuroinflammation-Associated Genes in the Rat Hippocampus
    Alexey A. Kvichansky, Liya V. Tret’yakova, Maria N. Volobueva, А. О. Манолова, M. Yu. Stepanichev, Mikhail V. Onufriev, Yulia V. Moiseeva, Н. А. Лазарева, Alexey P. Bolshakov, Natalia V. Gulyaeva · 2021 · Biochemistry (Moscow)
98. In Search of New Pharmacological Targets: Beyond Carnosine’s Antioxidant, Anti-Inflammatory, and Anti-Aggregation Activities
    Giuseppe Carota, Lucia Di Pietro, Vincenzo Cardaci, Anna Privitera, Francesco Bellia, Valentina Di Pietro, Giuseppe Lazzarino, Barbara Tavazzi, Angela Maria Amorini, Giacomo Lazzarino et al. · 2025 · Biocell
99. Potentiated fractalkine signaling axis affects neuroinflammation in 1,2-dichloroethane- intoxicated mice via divergent modulating ways on microglial hyperactivation
    Jinhan Yang, Jie Yang, Huiyi Hu, Weipeng Jiang, Xinxin Zhang, Gaoyang Wang, Fenghong Zhao, Yingjun Liao, Yaping Jin · 2025 · Ecotoxicology and Environmental Safety
100. The Immune-Chemokine Axis in Alzheimer’s Disease: Roles of Adaptive Immune System in Neuroinflammation and Disease Progression
     Jose Joaquín Merino, Jose Julio Rodriguez, Xavier Busquets, Isabel Álvarez-Vicente, María Eugenia Cabaña-Muñoz, Ana Isabel Flores, A. Tolédano · 2026 · Biomolecules